Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of lycomycin crystal form I and its preparation method and application

A lycomycin and crystal form technology, applied in the field of medicinal chemistry, can solve the problems affecting stability, bioavailability and curative effect, solubility, melting point, dissolution bioavailability, etc., and achieves low equipment requirements and stability. Good, pure and high content

Active Publication Date: 2022-04-26
LUOYANG HUIZHONG ANIMAL MEDICINE
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Different crystal forms of drugs may have significant differences in solubility, melting point, dissolution rate, bioavailability, etc., which will affect their stability, bioavailability and efficacy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of lycomycin crystal form I and its preparation method and application
  • A kind of lycomycin crystal form I and its preparation method and application
  • A kind of lycomycin crystal form I and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0040] The method for preparing lycomycin crystal form I as described in the first aspect of the present invention according to the second aspect of the present invention comprises the following steps:

[0041] S1, after adding acetone to lycomycin, stir and filter with suction to obtain the first filter cake;

[0042] S2, after adding ether and acetone to the first filter cake, heating, cooling, and suction filtration to obtain a second filter cake;

[0043] S3, washing and drying the second filter cake to obtain lycomycin crystal form I.

[0044] In some embodiments of the present invention, in step S1, 2-5 mL of acetone is added to each claricomycin.

[0045] In other embodiments of the present invention, in step S1, the stirring is performed at 20-30° C.; the stirring time is 1.0-1.5 h.

[0046] In some embodiments of the present invention, in step S2, 3-6 mL of ether and 1-2 mL of acetone are added to each gram of the first filter cake.

[0047] In other embodiments of...

Embodiment 1

[0060] Take 10 g of crude lycomycin, add 30 mL of acetone, stir at 25° C. for 1.0 h, and filter with suction to obtain the first filter cake. Add 40 mL of ether and 15 mL of acetone to the first filter cake, heat under reflux at 50° C. for 1.0 h, stop heating, cool to 25° C. with stirring, and suction filter to obtain the second filter cake. Add 10 mL of diethyl ether, wash the second filter cake, and blow dry at 50°C for 4 hours to obtain a white crystalline powder, which is lycomycin crystal form I, with a content of 98.3% and a yield of 80%.

[0061] The diffraction pattern of lycomycin crystal form I was determined by Bruker D8 ADVANCE X-ray powder diffractometer. Test conditions: CuKa 40kv 40mA, divergence slit 1.0mm, solar slit 0.4°; scanning method: continuous scanning; scanning step: 0.02°; scanning range: 3°-45°; scanning speed: 8° / min ; Detector: LynxEye. The result is as figure 1 As shown, the values ​​of the characteristic peaks in the figure are shown in Table ...

Embodiment 2

[0069] Take 10 g of crude lycomycin, add 20 mL of acetone, stir at 25° C. for 1.0 h, and filter with suction to obtain the first filter cake. Add 30 mL of ether and 10 mL of acetone to the first filter cake, heat under reflux at 50° C. for 1.0 h, stop heating, cool to 25° C. with stirring, and suction filter to obtain the second filter cake. Add 10 mL of diethyl ether, wash the second filter cake, and blow dry at 50° C. for 4 hours to obtain a white crystalline powder, lycomycin crystal form I, with a content of 97.6% and a yield of 83%.

[0070]Using the same method as in Example 1 to carry out X-ray powder diffraction detection of lycomycin crystal form I, the lycomycin crystal form I prepared in Example 2 and the lycomycin crystal form I prepared in Example 1 diffractogram They are basically the same, and there are characteristic absorption peaks at diffraction angles 2θ of 5.352°, 7.775°, 8.156°, 10.264°, 10.703°, 15.429°, and 16.652°, indicating that this method can be re...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a lycomycin crystal form I in the field of medicinal chemistry, a preparation method and application thereof. The lycomycin crystal form I, using Cu-Ka radiation, the X-ray diffraction pattern of the powder at the diffraction angle 2θ is 5.366±0.2°, 7.794±0.2°, 8.189±0.2°, 10.285±0.2°, 10.716±0.2 °, 15.432±0.2°, 16.655±0.2° have characteristic peaks. The preparation method of the lycomycin crystal form I includes the following steps: S1, after adding acetone to the lycomycin, stirring and suction filtration to obtain the first filter cake; S2, adding ether to the first filter cake After mixing with acetone, heating, cooling, and suction filtration to obtain a second filter cake; S3, washing and drying the second filter cake to obtain lycomycin crystal form I. The lycomycin crystal form I of the present invention has good stability, high purity and high content, and has good application prospects.

Description

technical field [0001] The invention belongs to the field of medicinal chemistry, and in particular relates to a crystal form I of lycomycin and its preparation method and application. Background technique [0002] Macrolide antibiotics, as an important class of anti-infective drugs, have become second only to β-endobacteria in clinical application due to their good antibacterial activity, no allergic reaction, small side effects, and high safety after 50 years of development. Amide antibiotics are the second largest class of anti-infective drugs and play an important role in clinical treatment. [0003] As the first-generation macrolide antibiotic, erythromycin was widely used to treat infections caused by Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus hemolyticus and Mycoplasma pneumoniae; azithromycin is the second-generation macrolide drug , has a wider antibacterial spectrum, has good antibacterial activity against Gram-negative bacilli, and has greatly...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07H17/08C07H1/06A61P31/04A61P33/02
Inventor 张许科张聪
Owner LUOYANG HUIZHONG ANIMAL MEDICINE